Gargi Pal,
Sanjay Paul,
Partha Pratim Ghosh and
Asish R. Das*
Department of Chemistry, University of Calcutta, Kolkata-700009, India. E-mail: ardchem@caluniv.ac.in; ardas66@rediffmail.com; Fax: +913323519754; Tel: +913323501014 Tel: +919433120265
First published on 2nd December 2013
A highly efficient and general protocol has been developed for the facile synthesis of highly diversified 1,3,5-trisubstituted pyrazoles and 3,5-disubstituted 2-isoxazolines through one-pot tandem intermolecular, as well as intramolecular, dipolar [3 + 2] cycloaddition reactions. Chemoselective oxidation of aldohydrazone to nitrile imine and aldoximes to nitrile oxides by iodosobenzene in neutral aqueous media was performed. The scope of the reactions in regiocontrolled dipolar cycloaddition with olefins in the presence of PhIO toward highly substituted pyrazole and isoxazoline derivatives has been demonstrated. SDS converted the initially floating reaction mass and the organo-oxidant PhIO into a homogeneous mixture, which on stirring became a turbid emulsion. The micellar arrangement was confirmed by dynamic light scattering and optical microscopy. The new, green and metal free synthetic method enabled the execution of regiocontrolled tandem cycloaddition oxidation sequences leading to a library of pyrazole and isoxazoline derivatives.
Iodosylarenes and their derivatives are generally strong oxidizing agents, and have found broad applications in organic synthesis as reagents for oxygenation and oxidative functionalization of organic substrates.7 The surging interest in iodine compounds, combined with their benign environmental character and commercial availability, encouraged our group to investigate a polyvalent iodine compound PhIO for use in the aforesaid dipolar cycloaddition reactions. The nitrile imine cycloaddition reactions are generally performed with unstable chloro- and bromoaldohydrazone precursors at higher temperatures in the presence of a base.8 In this paper, we wish to disclose the excellent oxidizing properties of iodosobenzene, as it has transformed aldohydrazone to nitrile imine and aldoximes to corresponding nitrile oxides in aqueous media at room temperature.
The temptation to exploit the virtues of eco-friendly reaction protocols was compelling, which led us to apply aqueous media for the cycloaddition reaction. The use of water reduces the use of harmful organic solvents and it is regarded as an important research topic in green chemistry.9 In addition, water has unique physical and chemical properties, and by utilizing these it would be possible to tune the reactivity or selectivity, which cannot be attained with organic solvents.10 However, organic reactions in water are often limited in scope due to the poor solubility of the organic compounds. This problem may be overcome by using surfactants to form colloidal dispersions with the organic compounds in water.
Herein, we report the application of PhIO in the presence of sodium dodecyl sulfate as the active surfactant for the intermolecular, as well as intramolecular, [3 + 2]-cycloadditions of 1,3-dipoles to dipolarophiles, leading to the formation of 1,3,5-trisubstituted pyrazoles in an aqueous environment for the first time. Furthermore, this optimized protocol was also extended to the synthesis of a set of 3,5-disubstituted 2-isoxazolines.
At the outset of this work, we examined the one-pot tandem cycloaddition reaction with 3-nitrobenzaldehyde (1), phenyl hydrazine (2) and methyl acrylate (3) as the model substrates (Scheme 1), in the presence of a wide spectrum of commercially available oxidants like CAN, CeCl3, chloramine-T, PhI(OAc)2, PhIO and metal Lewis acid catalysts in ethanol, at room temperature.
The initial investigation into the generation of the nitrile imine dipolar complex (I, Scheme 1) focused on the application of oxidants (Table 1, entries 1–5) and metal Lewis acid catalysts (Table 1, entries 6 and 7) to the one-pot tandem cycloaddition reaction with 3-nitrobenzaldehyde (1), phenyl hydrazine (2) and methyl acrylate (3) in ethanol medium. However, it was in vain. Gratifyingly, attempts with the organic oxidant iodosobenzene (PhIO) generated the dipolar complex (I, Scheme 1), and the expected pyrazole derivative was obtained. Ethanol was taken as the primary choice of the solvent as in this solvent all the reactants remained as a homogeneous mixture. One important facet of green chemistry is the eradication of solvents in chemical processes or the replacement of hazardous solvents with relatively benign solvents. Development of environmentally benign and economical syntheses is an area of research that is being vigorously pursued, by avoiding the use of harmful organic solvents. Hence, we have tried to synthesize the heterocyclic scaffold in aqueous media, applying a suitable surfactant/PhIO combination to enhance the rate of the reaction.
Entry | Additives | Reaction conditions | Time (h) | Yieldb (%) |
---|---|---|---|---|
a Reaction conditions: 3-nitrobenzaldehyde (1 mmol), phenyl hydrazine (1 mmol), methyl acrylate (1 mmol), 5 ml solvent, rt.b Isolated yields of pure products. | ||||
1 | CAN, 1.0 equiv. | EtOH | 24 | 0 |
2 | CeCl3, 1.0 equiv. | EtOH | 24 | 0 |
3 | Oxone, 1.0 equiv. | EtOH | 24 | 0 |
4 | Chloramine-T, 1.0 equiv. | EtOH | 24 | 0 |
5 | PhI(OAc)2, 1.0 equiv. | EtOH | 24 | 0 |
6 | Ni(OAc)2 | EtOH | 24 | 0 |
7 | Cu(OTf)2, (10 mol %) | EtOH | 24 | 0 |
8 | PhIO, 1.0 equiv. | EtOH | 8 | 28 |
9 | PhIO, 1.0 equiv. | H2O | 8 | 36 |
10 | PhIO, 1.0 equiv. | Triton X-100 (10 mol%), H2O | 7 | 41 |
11 | PhIO, 1.0 equiv. | CTAB (10 mol%), H2O | 7.5 | 43 |
12 | PhIO, 1.5 equiv. | SDS (10 mol%), H2O | 5 | 60 |
13 | PhIO, 2.0 equiv. | SDS (10 mol%), H2O | 5 | 89 |
14 | PhIO, 2.5 equiv. | SDS (10 mol%), H2O | 5 | 89 |
We have studied the influence of three commercially available surfactants, CTAB (cationic), SDS (anionic), and Triton X-100 (neutral), in search of suitable conditions in which to synthesize the heterocyclic scaffold in aqueous media. PhIO/SDS combinations outperformed all other oxidants and metal Lewis acid catalysts, in order to deliver the targeted scaffold at room temperature. It is pertinent to mention that the addition of surfactants converted the initially floating reaction mass into a homogeneous mixture, which on stirring became a turbid emulsion. The formation of a micellar system by using SDS enhanced the solubility and thereby the reactivity of PhIO. This observation implies that there was formation of micelles or colloidal aggregates. The average sizes of the colloidal particles formed from SDS and the reaction mixture in water were measured by dynamic light scattering (DLS), and the shape of the colloidal aggregates was nearly spherical with around 200 nm in diameter (Fig. 1b). Formation of emulsion droplets in the present reaction system was also confirmed by optical microscopy (Fig. 1a).
![]() | ||
Fig. 1 (a) Optical microscopic image showing micellar aggregates in the reaction media and (b) DLS study of the reaction media showing the formation of aggregates. |
To find the optimized amount of PhIO, the reaction was carried out by varying the amount of PhIO on the model reaction (Table 1). The conversion of pyrazole derivative increased linearly up to 2.0 equivalent of PhIO and became almost steady when the amount was further increased beyond this. Therefore 2.0 equivalents PhIO is sufficient to promote the reaction, leading to the expected heterocycles in excellent yields.
Having identified these optimal conditions, we set out to explore the scope for this new reaction, and the results are summarized in Table 2. All reactions were performed under the developed reaction conditions without individual optimization. At the R1 position, various electron-donating and electron-withdrawing groups on the aryl ring were compatible with the reaction conditions. Aliphatic and acid/base-sensitive heterocycles such as 2-thienyl and 2-furyl groups were also compatible with the mild [3 + 2] cycloaddition–oxidation reaction conditions (products 4e–g, 4n). Moreover, the one-pot tandem cycloaddition reaction was well established with a set of activated, as well as unactivated, dipolarophiles and excellent yields of the desired products.
a Reaction conditions: aldehyde (1 mmol), phenyl hydrazine (1 mmol), olefin (1 mmol), PhIO (2.0 mmol), SDS (10 mol%), 5 ml H2O, at room temperature for stipulated time. | |||
---|---|---|---|
![]() |
![]() |
![]() |
![]() |
4a, 85%, 6.5 h | 4b, 88%, 6 h | 4c, 91%, 5 h | 4d, 89%, 5 h |
![]() |
![]() |
![]() |
![]() |
4e, 87%, 5 h | 4f, 86%, 5 h | 4g, 91%, 4.5 h | 4h, 92%, 8 h |
![]() |
![]() |
![]() |
![]() |
4i, 81%, 8.5 h | 4j, 86%, 8 h | 4k, 87%, 8 h | 4l, 85%, 6 h |
![]() |
![]() |
![]() |
|
4m, 81%, 7 h | 4n, 84%, 6.5 h | 4o, 83%, 8.5 h |
Under the optimized reaction conditions, we also explored the synthesis of pyrazole derivatives, installing nitroolefin as the dipolarophile. This pyrazole formation reaction was quite general with respect to hydrazine and aldehydes with a variety of substituents, and the yields ranged from moderate to good. At the R1 position, both alkyl and aryl groups were well tolerated, providing multifunctionalized pyrazole derivatives (Table 3).
a Reaction conditions: aldehyde (1 mmol), phenyl hydrazine (1 mmol), β-nitrostyrene (1 mmol), 3 (1 mmol), PhIO (2.0 mmol), SDS (10 mol%), 5 ml H2O, at room temperature for stipulated time. | |||
---|---|---|---|
![]() |
![]() |
![]() |
![]() |
5a, 94%, 7 h | 5b, 81%, 7 h | 5c, 82%, 6.5 h | 5d, 82%, 8 h |
We have extended this green approach to the synthesis of various 3,5-disubstituted 2-isoxazolines (Table 4). Aryl, heteroaryl or alkyl groups at the R1 position afforded corresponding isoxazolines in excellent yields. In terms of R1 substituents, the meta-, and para-substituted aryl groups, and the electron-rich and electron-deficient aryl groups were also highly compatible, while the various activated, as well as unactivated, dipolarophiles easily provided good to excellent yields of the corresponding isoxazolines.
a Reaction conditions: aldehyde (1 mmol), hydroxy amine hydrochloride (1 mmol), sodium acetate (1 mmol), olefin (1 mmol), PhIO (1.0 mmol), SDS (10 mol%), 5 ml H2O, at room temperature for stipulated time. | |||
---|---|---|---|
![]() |
![]() |
![]() |
![]() |
6a, 92%, 2.5 h | 6b, 89%, 2.5 h | 6c, 84%, 3 h | 6d, 85%,3.5 h |
![]() |
![]() |
![]() |
![]() |
6e, 90%, 3 h | 6f, 90%, 3 h | 6g, 91%, 2.5 h | 6h, 92%, 2.5 h |
![]() |
|||
6i, 81%, 3 h |
Finally, the intramolecular cycloaddition oxidation reactions were also successful under the particular experimental conditions and afforded the corresponding biologically active chroman fused pyrazole, dihydro-isoxazole and an isoxazole derivative in excellent yields (Scheme 2).
In all cases, the progress of the reaction was monitored by TLC. The structures of the desired products were characterized by 1H and 13C NMR, IR and HRMS spectral data. The X-ray crystal structures (see ESI†) of 1,3,5-trisubstituted pyrazole (Fig. 2a) and 3,5-disubstituted 2-isoxazoline (Fig. 2b) further confirmed the product identities.
![]() | ||
Fig. 2 (a) ORTEP diagram of the single-crystal X-ray structure of 4-(4-fluoro-phenyl)-3-isopropyl-1-phenyl-1H-pyrazole (5a).† (b) ORTEP diagram of the single-crystal X-ray structure of 3-(4-bromo-phenyl)-5-phenyl-4,5-dihydro-isoxazole (6f).† |
The reaction driving force in micelles may be related to the hydrophobic force, which compressed the reactants together in a highly compact arrangement of complexes within a restricted, hydrophobic domain. In light of the above results, a revised mechanism of pyrazole and isoxazoline formation may be proposed, as outlined in Schemes 3, 4 and 5. Thus, the most likely pathway for the cycloaddition is proposed to be as follows: Initially the reaction passed through a simple condensation reaction between the aldehyde and nitrogen nucleophile to produce the corresponding aldohydrazone (Scheme 3, I) and aldoxime (Scheme 5, I) compounds. Then, in the case of pyrazole formation (Scheme 3), the N-benzylidene-N′-phenyl-hydrazine (I) was oxidized by an equivalent of PhIO, to generate the corresponding nitrile imine dipolar species (III) with the concomitant loss of PhI and a water molecule. Nitrile imine dipolar species followed the unidirectional formal [3 + 2]-cycloaddition pathways with the olefinic substrate, to afford the five-member heterocycles (IV). Next, the cycloaddition product (Scheme 3, IV) was smoothly oxidised by another equivalent of PhIO giving an aromatic pyrazole nucleus (Scheme 3, P).
During the reaction of hydrazone with nitroolefin, the nucleophilic attack of hydrazone to nitroolefin afforded a Michael addition product V, which did not cyclize to a pyrazolidine intermediate IV under the reaction conditions. PhIO has shown excellent activity in promoting the reaction to the desired track, by oxidizing the hydrazone to the corresponding nitrile imine dipolar species12 which cannot undergo Michael addition reaction. Then a concerted cycloaddition reaction takes place to give a 4-nitropyrazolidine intermediate IV. The key intermediate IV then undergoes a slow oxidation by PhIO, to furnish the pyrazole product (P) by the elimination of HNO2.
During the formation of isoxazolines, PhIO oxidized aldoximes to nitrile oxides via the transition state II (Scheme 5), which then participated in a cycloaddition to an unsaturated bond, giving the desired product. In case of isoxazoline derivatives, a further aromatization step was not achieved even after increasing the amount of PhIO. Hence, one equivalent of PhIO was sufficient to promote the dipolar cycloaddition reaction.
The reaction of N-monosubstituted hydrazones and oximes with various 1,3-dipolar species showed excellent regioselectivity under the developed reaction conditions. No side products, such as cycloaddition products X, Y or the Michael addition product V (Fig. 3), were isolated during the course of the reaction. Hence the reaction was completely regiocontrolled, and this feature made the PhIO mediated cycloaddition reaction a high yielding synthetic protocol for obtaining the desired pyrazole and isoxazoline derivatives.
1H NMR (300 MHz, CDCl3): δ 8.62 (s, 1H), 8.15–8.05 (m, 2H), 7.78 (d, 1H, J = 8.4 Hz), 7.55–7.41 (m, 4H), 7.33 (s, 1H), 7.24 (t, 1H, J = 8 Hz), 3.76 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 164.1, 149.2, 142.8, 139.1, 135.1, 131.1, 129.8, 129.5, 128.6, 128.2, 126.1, 123.7, 123.1, 120.7, 113.5, 109.7, 52.3; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C17H14N3O4: 324.0984, found: 324.0980; IR (KBr) cm−1: 1089.7, 1248.8, 1347.1, 1525.1, 1601.8, 1736.9, 2955.3, 3285.9; anal. calcd for C17H13N3O4: C: 63.16; H: 4.05; N: 13.00%, found: C: 63.11; H: 4.01; N: 13.01%.
1H NMR (300 MHz, CDCl3): δ 8.28 (d, 2H, J = 8.7 Hz), 7.80 (d, 2H, J = 8.7 Hz), 7.66 (d, 2H, J = 8.7 Hz), 7.40–7.29 (m, 4H), 4.26 (q, 2H, J = 7.1), 1.27 (t, 3H, J = 7.2); 13C NMR (75 MHz, CDCl3): δ 158.9, 152.8, 147.2, 145.0, 134.9, 131.5, 128.9, 126.5, 125.9, 124.0, 123.9, 111.0, 67.7, 14.1; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C18H16N3O4: 338.1141, found: 338.1140; IR (KBr) cm−1: 1110, 1241.7, 1306.8, 1526.4, 1597.9, 1721.7, 2937.8, 3132.8; anal. calcd for C18H15N3O4: C: 64.09; H: 4.48; N: 12.46%, found: C: 64.09; H: 4.46; N: 12.42%.
1H NMR (300 MHz, CDCl3): δ 7.76 (s, 1H), 7.62 (d, 2H, J = 7.8 Hz), 7.40–7.14 (m, 5H), 7.06–6.97 (m, 2H), 3.13 (m, 1H), 1.25 (d, 6H, J = 6.9 Hz); 13C NMR (75 MHz, CDCl3): δ 157.2, 140.2, 137.5, 130.1, 129.9, 129.4, 127.5, 126.5, 126.1, 125.4, 121.6, 118.8, 115.6, 115.3, 114.9, 26.5, 22.6; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C18H18FN2: 281.1454, found: 281.1450; IR (KBr) cm−1: 1174.8, 1241.2, 1504.3, 1575.5, 1608.9, 2850.8; anal. calcd for C18H17FN2: C: 77.12; H: 6.11; N: 9.99%, found: C: 77.10; H: 6.10; N: 9.98%.
1H NMR (300 MHz, CDCl3): δ 7.80 (dd, 1H, J = 7.5 Hz, 1.8 Hz), 7.65–7.60 (m, 2H), 7.41–7.34 (m, 3H), 7.24–7.12 (m, 1H), 6.98–6.87 (m, 3H), 5.27 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 156.4, 154.1, 135.8, 133.1, 130.0, 129.6, 129.1, 126.3, 122.7, 122.3, 122.1, 122.1, 119.2, 117.4, 63.3; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C16H13N2O: 249.1028, found: 249.1025; IR (KBr) cm−1: 1089.6, 1229.8, 1471.3, 1502.8, 1599.3, 1689.9, 2800.3; anal. calcd for C16H12N2O: C: 77.40; H: 4.87; N: 11.28%, found: C: 77.45; H: 4.84; N: 11.25%.
1H NMR (300 MHz, CDCl3): δ 8.30 (s, 1H), 8.17 (d, 1H, J = 8.4 Hz), 7.98 (d, 1H J = 7.8 Hz), 7.56–7.51 (m, 1H), 5.22 (dd, 1H, J = 10.2, 7.8 Hz), 4.20 (q, 2H, J = 7.1 Hz), 3.70–3.63 (m, 2H), 1.25 (t, 3H, J = 7.2 Hz); 13C NMR (75 MHz, CDCl3): δ 169.8, 154.6, 148.3, 132.4, 130.1, 129.8, 124.9, 121.9, 78.8, 62.4, 38.4, 14.1; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C12H13N2O5: 265.0824, found: 265.0820; IR (KBr) cm−1: 1145.7, 1210.9, 1463.7,1548.1, 1720.6, 2863.3, 2933.4, 3012.3, 3548.5; anal. calcd for C12H13N2O5: C: 54.55; H: 4.58; N: 10.60%, found: C: 54.54; H: 4.56; N: 10.62%.
1H NMR (300 MHz, CDCl3): δ 7.65–7.51 (m, 2H), 7.31–7.21 (m, 8H), 5.61 (dd, 1H, J = 10.2, 8.1 Hz), 3.65 (dd, 1H, J = 16.6,10.8 Hz), 3.21 (dd, 1H, J = 16.8, 8.4 Hz); 13C NMR (75 MHz, CDCl3): δ 156.0, 140.8, 137.4, 130.2, 129.1, 129.0, 128.1, 128.0, 126.1, 125.9, 82.5, 43.1; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C15H14NO: 224.1075, found: 224.1072; IR (KBr) cm−1: 1059.3, 1212.7, 1453.0, 1599.6, 2830, 3030.2, 3532.2; anal. calcd for C15H13NO: C: 80.69; H: 5.87; N: 6.27%, found: C: 80.66; H: 5.89; N: 6.29%.
1H NMR (300 MHz, CDCl3): δ 7.68 (d, 1H, J = 7.5 Hz), 7.26–7.18 (m, 1H), 6.92–6.83 (m, 2H), 4.60–4.53 (m, 2H), 4.01–3.94 (m, 1H), 3.89–3.75 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 155.6, 152.8, 132.5, 125.6, 121.8, 117.4, 113.0, 70.6, 69.2, 45.9; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C10H10NO2: 176.0712, found: 176.0710; IR (KBr) cm−1: 1026.3, 1209.2, 1410.4, 1560.3, 1710.1, 2896.3, 3010.5, 3566.9; anal. calcd for C10H9NO2: C: 68.56; H: 5.18; N: 8.00%, found: C: 68.58; H: 5.16; N: 8.01%.
1H NMR (300 MHz, CDCl3): δ 8.24 (s, 1H), 7.91 (dd, 1H, J = 7.6, 1.5 Hz), 7.42–7.36 (m, 1H), 7.16–7.04 (m, 2H), 5.27 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 154.8, 153.6, 150.6, 132.1, 124.5, 122.4, 117.9, 113.9, 111.1, 61.3; HRMS (ESI-TOF) m/z: [M + H]+ calculated for C10H8NO2: 174.0555, found: 174.0553; IR (KBr) cm−1: 1045.6, 1211.8,1496.8, 1501.1, 1705.1, 2988.9, 3112.5, 3496.9; anal. calcd for C10H7NO2: C: 69.36; H: 4.07; N: 8.09%, found: C: 69.38; H: 4.09; N: 8.07%.
Footnote |
† Electronic supplementary information (ESI) available. CCDC 941068 (5a) and 945312 (6f). For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c3ra46129g |
This journal is © The Royal Society of Chemistry 2014 |